New immunosuppressive drugs in heart transplantation

about

Micro RNA-98 suppresses interleukin-10 in peripheral B cells in patient post-cardio transplantation.Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

P2860

Q33709652-AF2E6C42-BDA4-402E-8281-07EA0B22F3AA Q38065993-29C288C1-815D-4643-8402-07CC4FD1A2AF

P2860

New immunosuppressive drugs in heart transplantation

Item

http://www.wikidata.org/entity/Q24793542

description

2001 nî lūn-bûn

@nan

2001 թուականին հրատարակուած գիտական յօդուած

@hyw

2001 թվականին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

New immunosuppressive drugs in heart transplantation

@ast

New immunosuppressive drugs in heart transplantation

@en

New immunosuppressive drugs in heart transplantation

@nl

type

Item

label

New immunosuppressive drugs in heart transplantation

@ast

New immunosuppressive drugs in heart transplantation

@en

New immunosuppressive drugs in heart transplantation

@nl

prefLabel

New immunosuppressive drugs in heart transplantation

@ast

New immunosuppressive drugs in heart transplantation

@en

New immunosuppressive drugs in heart transplantation

@nl

P1476

New immunosuppressive drugs in heart transplantation

@en

P2093

Maria Rosa Costanzo

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

Immunosuppressive strategies in transplantation.

Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis.

Cardiopulmonary effects of OKT3: determinants of hypotension, pulmonary edema, and cardiac dysfunction.

The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.

Chimeric monoclonal CD4 antibody--a novel immunosuppressant for clinical heart transplantation.

OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.

Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

Effect of pravastatin on outcomes after cardiac transplantation.

P2888

cvm-2-1-045

P304

45-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CVM-2-1-045

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11552005

http://www.w3.org/2001/XMLSchema#string

P6179

1051061382

http://www.w3.org/2001/XMLSchema#string

P698

11806772

http://www.w3.org/2001/XMLSchema#string

P932

59653

http://www.w3.org/2001/XMLSchema#string

New immunosuppressive drugs in heart transplantation

about

P2860

P2860

New immunosuppressive drugs in heart transplantation

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932